Alphatec Holdings vs Myriad Genetics
Alphatec Holdings and Myriad Genetics are similar in size: $764m and $825m of revenue in their latest fiscal years. Alphatec Holdings grew faster (25.0% against -1.6%). Alphatec Holdings kept more of each dollar of sales as profit: a net margin of -18.8% against -44.4%. Myriad Genetics carries less debt relative to equity (34.0% against 5566.3%).
| Latest fiscal year | Alphatec HoldingsATEC, 2025 | Myriad GeneticsMYGN, 2025 |
|---|---|---|
| Revenue | $764m | $825m |
| Revenue growth | 25.0% | -1.6% |
| Net income | −$143m | −$366m |
| Operating margin | -10.7% | -47.0% |
| Net margin | -18.8% | -44.4% |
| Return on equity | — | -68.5% |
| Free cash flow | $2.8m | $1.8m |
| Cash | $161m | $150m |
| Total debt | $692m | $125m |
| Debt to equity | 5566.3% | 34.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 913 | 2,700 |
| Market value | $1.17bn | $567m |
| Price vs our value range | — | — |
| Moat score | 28 (Weak) | 26 (Weak) |
| Insider trades, 12 months | 5 buys, 41 sales | 5 buys, 1 sales |